Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study.
Saved in:
| Title: | Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study. |
|---|---|
| Authors: | Fanti S; Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy; stefano.fanti@aosp.bo.it., Robles Barba JJ; Nuclear Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Behr S; University of California San Francisco, San Francisco, California., Maurer T; Department of Urology and Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, Hamburg, Germany., Paredes P; Clinic Hospital Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain., Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France., Duch J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Perdigo MS; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Mainta IC; Division of Nuclear Medicine, Diagnostic Department, Geneva University Hospitals, University of Geneva, Geneva, Switzerland., Bonnefoy PB; Service de Médecine Nucléaire, CHU de Saint-Etienne, Saint-Étienne, France., Coulanges M; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland., Tang J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Seigne C; Novartis Pharma AG, Basel, Switzerland; and., Wilke C; Novartis Pharma AG, Basel, Switzerland; and., Catafau AM; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland., Iagaru A; Stanford University, Stanford, California., Aggarwal R; University of California San Francisco, San Francisco, California. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Aug 01; Vol. 66 (8), pp. 1210-1216. Date of Electronic Publication: 2025 Aug 01. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40473464 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Imaging Efficacy of [<superscript>18</superscript>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fanti+S%22">Fanti S</searchLink>; Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy; stefano.fanti@aosp.bo.it.<br /><searchLink fieldCode="AU" term="%22Robles+Barba+JJ%22">Robles Barba JJ</searchLink>; Nuclear Medicine, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Behr+S%22">Behr S</searchLink>; University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Maurer+T%22">Maurer T</searchLink>; Department of Urology and Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Paredes+P%22">Paredes P</searchLink>; Clinic Hospital Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Walz+J%22">Walz J</searchLink>; Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Duch+J%22">Duch J</searchLink>; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Perdigo+MS%22">Perdigo MS</searchLink>; Hospital Universitari Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mainta+IC%22">Mainta IC</searchLink>; Division of Nuclear Medicine, Diagnostic Department, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bonnefoy+PB%22">Bonnefoy PB</searchLink>; Service de Médecine Nucléaire, CHU de Saint-Etienne, Saint-Étienne, France.<br /><searchLink fieldCode="AU" term="%22Coulanges+M%22">Coulanges M</searchLink>; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tang+J%22">Tang J</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.<br /><searchLink fieldCode="AU" term="%22Seigne+C%22">Seigne C</searchLink>; Novartis Pharma AG, Basel, Switzerland; and.<br /><searchLink fieldCode="AU" term="%22Wilke+C%22">Wilke C</searchLink>; Novartis Pharma AG, Basel, Switzerland; and.<br /><searchLink fieldCode="AU" term="%22Catafau+AM%22">Catafau AM</searchLink>; Advanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Iagaru+A%22">Iagaru A</searchLink>; Stanford University, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Aggarwal+R%22">Aggarwal R</searchLink>; University of California San Francisco, San Francisco, California. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2025 Aug 01; Vol. 66 (8), pp. 1210-1216. <i>Date of Electronic Publication: </i>2025 Aug 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40473464 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2967/jnumed.124.269266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1210 Titles: – TitleFull: Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath-A Phase 3, Prospective Multicenter Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fanti S – PersonEntity: Name: NameFull: Robles Barba JJ – PersonEntity: Name: NameFull: Behr S – PersonEntity: Name: NameFull: Maurer T – PersonEntity: Name: NameFull: Paredes P – PersonEntity: Name: NameFull: Walz J – PersonEntity: Name: NameFull: Duch J – PersonEntity: Name: NameFull: Perdigo MS – PersonEntity: Name: NameFull: Mainta IC – PersonEntity: Name: NameFull: Bonnefoy PB – PersonEntity: Name: NameFull: Coulanges M – PersonEntity: Name: NameFull: Tang J – PersonEntity: Name: NameFull: Seigne C – PersonEntity: Name: NameFull: Wilke C – PersonEntity: Name: NameFull: Catafau AM – PersonEntity: Name: NameFull: Iagaru A – PersonEntity: Name: NameFull: Aggarwal R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1535-5667 Numbering: – Type: volume Value: 66 – Type: issue Value: 8 Titles: – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Type: main |
| ResultId | 1 |